Sale!
Replica Targeted EGFR Inhibitor for EGFR NSCLC (Ex19Del, L858R)
Replica Targeted EGFR Inhibitor for EGFR NSCLC (Ex19Del, L858R) - Image 2

Replica Targeted EGFR Inhibitor for EGFR NSCLC (Ex19Del, L858R)

Original price was: $615.00.Current price is: $456.00.

Targeted drug, treats EGFR-mutated NSCLC, third-generation irreversible EGFR-TKI, inhibits EGFR Ex19Del and EGFR L858R mutations, anti-metastasis effect to CNS,

SKU: SKU67EJPAI9H Category:
Contact via Email Contact via WhatsApp
Guaranteed Safe Checkout

Targeted drug, treats EGFR-mutated NSCLC, third-generation irreversible EGFR-TKI, inhibits EGFR Ex19Del and EGFR L858R mutations, anti-metastasis effect to CNS,

Related products

Scroll to Top